Related Experiment Video
Updated: Dec 21, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Promising Immuno-Oncology Options for the Future: Cellular Therapies and Personalized Cancer Vaccines
Benjamin J Solomon1, Paul A Beavis1, Philip K Darcy1
1Peter MacCallum Cancer Centre, Melbourne, Australia.
Abstract:
A common pathway for an effective immune anticancer response involves recognition of tumor neoantigens and subsequent targeting of cancer cells by T cells. In this article, we provide an overview of the current status of two approaches to directly enhance this interaction using either adoptive cell therapy or personalized cancer vaccines with focus on recent advances in solid tumors, including lung cancer.
Insights
This review explores adoptive cell therapy and personalized cancer vaccines, two strategies to boost T cell-mediated anti-cancer immune responses against solid tumors like lung cancer.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Effective anti-cancer immunity relies on T cells recognizing tumor neoantigens.
- Enhancing T cell-mediated tumor cell targeting is a key therapeutic goal.
Purpose of the Study:
- To review current advancements in adoptive cell therapy (ACT) and personalized cancer vaccines.
- To focus on the application of these immunotherapies in solid tumors, specifically lung cancer.
Main Methods:
- Overview of existing research and recent clinical progress in ACT.
- Review of developments in personalized cancer vaccine strategies.
- Analysis of challenges and successes in solid tumor treatment.
Main Results:
- ACT and personalized vaccines show promise in enhancing anti-tumor immune responses.
- Recent advances have improved the efficacy of these therapies in solid tumors.
- Lung cancer is a significant focus for these therapeutic strategies.
Conclusions:
- Adoptive cell therapy and personalized cancer vaccines represent promising avenues for cancer immunotherapy.
- Further research and clinical trials are crucial to optimize their use in solid tumors.
- These approaches hold potential for improving patient outcomes in lung cancer and other solid malignancies.
More Related Videos
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microorganisms in Medicine and Therapeutics
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

